Schrödinger, Inc. (NASDAQ:SDGR – Get Rating) traded down 10.7% on Friday following a weaker than expected earnings announcement. The company traded as low as $29.90 and last traded at $31.00. 16,838 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 503,570 shares. The stock had previously closed at $34.71.
The company reported ($0.67) EPS for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.06). Schrödinger had a negative return on equity of 23.72% and a negative net margin of 87.27%. The company had revenue of $38.50 million during the quarter, compared to the consensus estimate of $35.48 million. During the same quarter in the previous year, the business posted ($0.49) EPS. The firm’s revenue for the quarter was up 29.2% on a year-over-year basis.
Analyst Upgrades and Downgrades
Separately, Piper Sandler raised their price target on Schrödinger from $84.00 to $86.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 26th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $68.83.
Institutional Trading of Schrödinger
Schrödinger Stock Down 3.3 %
The stock has a 50 day moving average of $28.99 and a 200 day moving average of $28.89. The company has a market capitalization of $2.39 billion, a price-to-earnings ratio of -17.77 and a beta of 1.14.
Schrödinger Company Profile
Schrödinger, Inc, together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.
- Get a free copy of the StockNews.com research report on Schrödinger (SDGR)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.